Markets:

Overview

News

Currencies

International

Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

3.410 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sana Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes

November 17, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis

November 09, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates

November 08, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting

November 02, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200M

October 10, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 13, 2023

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 13, 2023

Via Benzinga

Sana Biotechnology to Present at September 2023 Investor Conferences

August 30, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023 ↗

August 14, 2023

Via Benzinga

Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates

August 03, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

3 Hidden Penny Stocks That Could Turn $100 into $10,000 ↗

July 31, 2023

These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

Via InvestorPlace

Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023 Annual Meeting

June 16, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at June 2023 Investor Conferences

May 31, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday ↗

May 30, 2023

U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

Sana Biotechnology Announces Preclinical Data Published in Nature Biotechnology Demonstrating its Hypoimmune-Engineered Cells Escape Immune Detection and Survive While Remaining Fully Functional

May 08, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports First Quarter 2023 Financial Results and Business Updates

May 08, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

7 High-Potential Penny Stocks in the Biotech Sector ↗

May 04, 2023

Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider.

Via InvestorPlace

Sana Biotechnology to Present at May 2023 Investor Conferences

May 03, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces the Acceptance of Six Abstracts for Presentation at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting

May 02, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 ↗

May 02, 2023

Via Benzinga

Sana Biotechnology to Host Research & Development Day

April 24, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

The Top 3 Biotech Stocks to Watch in 2023 ↗

April 20, 2023

Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.

Via InvestorPlace

Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with Four Presentations at the 2023 AACR Annual Meeting

April 19, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher? ↗

April 17, 2023

Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.

Via The Motley Fool

Why Shares of Sana Biotechnology Jumped This Week ↗

April 14, 2023

The company announced details of research on two of its pre-clinical therapies.

Via The Motley Fool

Why Sana Biotechnology Shares Are Trading Higher Today ↗

April 13, 2023

Sana Biotechnology (NASDAQ: SANA) shares are trading higher after the company announced the publication of a paper in Nature Communications on hypoimmune-modified allogeneic CD19-directed CAR T cells.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.